Derivati di pirazina quali bloccanti di ENaC

Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical composit...

Full description

Saved in:
Bibliographic Details
Main Authors SMITH NICHOLA, EDWARDS LEE, HUNT PETER, BHALAY GURDIP, HOWSHAM CATHERINE
Format Patent
LanguageItalian
Published 09.07.2015
Online AccessGet full text

Cover

Abstract Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
AbstractList Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
Author HOWSHAM CATHERINE
HUNT PETER
BHALAY GURDIP
EDWARDS LEE
SMITH NICHOLA
Author_xml – fullname: SMITH NICHOLA
– fullname: EDWARDS LEE
– fullname: HUNT PETER
– fullname: BHALAY GURDIP
– fullname: HOWSHAM CATHERINE
BookMark eNrjYmDJy89L5WTQcUktyixLLMlUSMlUKMgsSqzKzEtUKCxNzMlUSMrJT05OzIPIufolOvMwsKYl5hSn8kJpbgYlN9cQZw_d1IL8-NTigsTk1LzUkvhg3xAjA0NTAwNDY2MnY6IUAQCXyitr
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID SMT201500133B
GroupedDBID EVB
ID FETCH-epo_espacenet_SMT201500133B3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:16:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Italian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SMT201500133B3
Notes Application Number: SM20150000133T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150709&DB=EPODOC&CC=SM&NR=T201500133B
ParticipantIDs epo_espacenet_SMT201500133B
PublicationCentury 2000
PublicationDate 20150709
PublicationDateYYYYMMDD 2015-07-09
PublicationDate_xml – month: 07
  year: 2015
  text: 20150709
  day: 09
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies NOVARTIS AG
RelatedCompanies_xml – name: NOVARTIS AG
Score 2.9861326
Snippet Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as...
SourceID epo
SourceType Open Access Repository
Title Derivati di pirazina quali bloccanti di ENaC
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150709&DB=EPODOC&locale=&CC=SM&NR=T201500133B
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6JOJYj0yWJd044-FKFpyxDaDVdlbyMfLRRhDlcR_Ou9hE73tLckB_k4crnfJXcXgDtP8iGqmYHtKMexqaoebVFJnUUUwazkrhdwbShmuT96pc8zb9aB93UsjMkT-m2SI6JESZT3xpzXy_9LrNj4Vq4eRI1NH09pEcZWax1rdOMEVhyFyWQcj5nFWDjNrPwlLAwR8Y4b7cCuxtE60X7yFumwlOWmTkmPYG-C3S2aY-jUTQ8O2PrrtR7sZ-2LNxZb4VudwH2Mu0XfoBJVE_0-_lMvODFRkUSgTtJMMrQk5-wUbtOkYCMbh53_LXI-zTam6J5BF63_8hxIiQCAUyHRcHKpHFJR-jLwK6o8JYVfDS6gv6Wjy63UPhzqivE-Da6g23x-ldeoYxtxY3jzC3kxfzg
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTkWdH0WkTxbrmrb0oQj9ouraDVdlbyVJWyjCHK4i-Nd7CZ3uaW8hB_k4crnf3eUuADcmpzaqmaGmF7qukaK611jFRRVRBLOcGqZDhaGYpFb8Sp5m5qwD76tcGFkn9FsWR0SJ4ijvjbyvF_9OrEC-rVzesRq7Ph6izA3U1joW6EZ31MBzw8k4GPuq77vTRE1f3EwSEe8Y3hZs26I8r8BOb55IS1ms65RoH3YmONy8OYBO3fSh56--XuvDbtJGvLHZCt_yEG4DPC3Cg6oUtSLi4z_1nCoyK1JhqJMEkyQtTKl_BNdRmPmxhtPmf5vMp8naEo1j6KL1X56AUiIAoIRxNJwMwm3CSos7VkUKs-DMqoanMNgw0NlG6hX04iwZ5aPH9HkAe4IgX6I659BtPr_KC9S3DbuUfPoFlDSCJQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Derivati+di+pirazina+quali+bloccanti+di+ENaC&rft.inventor=SMITH+NICHOLA&rft.inventor=EDWARDS+LEE&rft.inventor=HUNT+PETER&rft.inventor=BHALAY+GURDIP&rft.inventor=HOWSHAM+CATHERINE&rft.date=2015-07-09&rft.externalDBID=B&rft.externalDocID=SMT201500133B